insitro.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $1.26B
Insitro is a drug discovery and development business using machine learning methods to create predictive models for treatments. Insitro's use of technology and quantitative biology aims to model disease and develop new therapies. Insitro was founded in 2018 by Daphne Koller Ph.D. and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/15/2021 | Series C | $400MM | $xx.xx | $2.57B | Alexandria Venture Investments, Andreessen Horowitz, Arch Venture Partners, Blackrock, Casdin Capital, Cpp Investments, Foresite Capital, Gv, Hof Capital, Softbank, Temasek, Third Rock Ventures, T. Rowe Price, Two Sigma Ventures | |
Price per Share
$xx.xx
Shares Outstanding
21,868,541
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Venture Investments, Andreessen Horowitz, Arch Venture Partners, Blackrock, Casdin Capital, Cpp Investments, Foresite Capital, Gv, Hof Capital, Softbank, Temasek, Third Rock Ventures, T. Rowe Price, Two Sigma Ventures
|
||||||
05/26/2020 | Series B | $149.22MM | $xx.xx | $725.03MM | Alexandria Venture Investments, Andreessen Horowitz, Arch Venture Partners, Blackrock, Casdin Capital, Cpp Investments, Foresite Capital, Gv, Hof Capital, Third Rock Ventures, T. Rowe Price, Two Sigma Ventures, Wuxi Apptec | |
Price per Share
$xx.xx
Shares Outstanding
23,949,729
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Venture Investments, Andreessen Horowitz, Arch Venture Partners, Blackrock, Casdin Capital, Cpp Investments, Foresite Capital, Gv, Hof Capital, Third Rock Ventures, T. Rowe Price, Two Sigma Ventures, Wuxi Apptec
|
||||||
05/01/2018 | Series A-1 | $30MM | $xx.xx | $309.11MM | A16z, Alexandria Venture, Arch Venture, Bezos Expeditions, Foresite Capital, Gv, Mubadala Investment Company, Third Rock Ventures, Two Sigma Ventures, Verily | |
Price per Share
$xx.xx
Shares Outstanding
33,327,366
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
A16z, Alexandria Venture, Arch Venture, Bezos Expeditions, Foresite Capital, Gv, Mubadala Investment Company, Third Rock Ventures, Two Sigma Ventures, Verily
|
||||||
05/01/2018 | Series A-2 | $49.41MM | $xx.xx | $309.11MM | A16z, Alexandria Venture, Arch Venture, Bezos Expeditions, Foresite Capital, Gv, Mubadala Investment Company, Third Rock Ventures, Two Sigma Ventures, Verily | |
Price per Share
$xx.xx
Shares Outstanding
18,359,806
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
A16z, Alexandria Venture, Arch Venture, Bezos Expeditions, Foresite Capital, Gv, Mubadala Investment Company, Third Rock Ventures, Two Sigma Ventures, Verily
|